<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss"  xmlns:media="http://search.yahoo.com/mrss/">
<channel>
	<title><![CDATA[Hannadex: Roche, Reloaded]]></title>
	<link>http://hannadex.com/pages/view/2872/roche-reloaded</link>
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">http://hannadex.com/pages/view/2872/roche-reloaded</guid>
	<pubDate>Tue, 21 May 2013 15:00:00 -0400</pubDate>
	<link>http://hannadex.com/pages/view/2872/roche-reloaded</link>
	<title><![CDATA[Roche, Reloaded]]></title>
	<description><![CDATA[

<p>Roche has one of the best long-term growth profiles in the Big Pharma space<br /></p>
<hr>

<p><br />Original: <a href="http://www.investopedia.com/stock-analysis/052113/roche-reloaded-rhhby-bmy-gild-mrk-jnj.aspx?partner=rss_stock_analysis">http://www.investopedia.com/stock-analysis/052113/roche-reloaded-rhhby-bmy-gild-mrk-jnj.aspx?partner=rss_stock_analysis</a> <br />Posted: May 21, 2013, 3:00 pm</p>

]]></description>
	<dc:creator>Adminhindex</dc:creator>
</item>

</channel>
</rss>